Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Articles by Review for PubMed (Select 11332767)

1.

Neuronal ceroid lipofuscinoses: classification and diagnosis.

Wisniewski KE, Kida E, Golabek AA, Kaczmarski W, Connell F, Zhong N.

Adv Genet. 2001;45:1-34. Review.

PMID:
11332767
2.

Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.

Kida E, Golabek AA, Wisniewski KE.

Adv Genet. 2001;45:35-68. Review.

PMID:
11332776
3.

Neuronal ceroid lipofuscinoses: research update.

Wisniewski KE, Kida E, Connell F, Zhong N.

Neurol Sci. 2000;21(3 Suppl):S49-56. Review.

PMID:
11073228
4.

The molecular genetic basis of the neuronal ceroid lipofuscinoses.

Gardiner RM.

Neurol Sci. 2000;21(3 Suppl):S15-9. Review.

PMID:
11073223
5.

Pheno/genotypic correlations of neuronal ceroid lipofuscinoses.

Wisniewski KE, Zhong N, Philippart M.

Neurology. 2001 Aug 28;57(4):576-81. Review.

PMID:
11548735
6.

Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses.

Kousi M, Lehesjoki AE, Mole SE.

Hum Mutat. 2012 Jan;33(1):42-63. doi: 10.1002/humu.21624. Epub 2011 Nov 16. Review.

PMID:
21990111
7.

The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease.

Weimer JM, Kriscenski-Perry E, Elshatory Y, Pearce DA.

Neuromolecular Med. 2002;1(2):111-24. Review.

PMID:
12025857
8.

Molecular genetics of the neuronal ceroid lipofuscinoses.

Mole S, Gardiner M.

Epilepsia. 1999;40 Suppl 3:29-32. Review.

PMID:
10446748
9.

Current state of clinical and morphological features in human NCL.

Goebel HH, Wisniewski KE.

Brain Pathol. 2004 Jan;14(1):61-9. Review.

PMID:
14997938
10.

Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.

Mole SE, Mitchison HM, Munroe PB.

Hum Mutat. 1999;14(3):199-215. Review.

PMID:
10477428
11.

Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Mole SE, Williams RE, Goebel HH.

Neurogenetics. 2005 Sep;6(3):107-26. Epub 2005 Sep 28. Review.

PMID:
15965709
12.

Molecular genetic analysis of neuronal ceroid lipofuscinosis.

Mole SE, Gardiner M.

Int J Neurol. 1991-1992;25-26:52-9. Review.

PMID:
11980063
13.

Atypical late infantile and juvenile forms of neuronal ceroid lipofuscinosis and their diagnostic difficulties.

Wiśniewski KE, Zhong N, Kida E, Kaczmarski W, Kaczmarski A, Connell F, Brooks SS, Brown WT.

Folia Neuropathol. 1997;35(2):73-9. Review.

PMID:
9377079
14.

Human pathology in NCL.

Anderson GW, Goebel HH, Simonati A.

Biochim Biophys Acta. 2013 Nov;1832(11):1807-26. doi: 10.1016/j.bbadis.2012.11.014. Epub 2012 Nov 29. Review.

15.

The neuronal ceroid-lipofuscinoses.

Goebel HH.

Semin Pediatr Neurol. 1996 Dec;3(4):270-8. Review.

PMID:
8969009
16.

The neuronal ceroid-lipofuscinoses (Batten disease): a new class of lysosomal storage diseases.

Bennett MJ, Hofmann SL.

J Inherit Metab Dis. 1999 Jun;22(4):535-44. Review.

PMID:
10407785
17.

Neuronal Ceroid-Lipofuscinoses.

Mole SE, Williams RE.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015.
2001 Oct 10 [updated 2013 Aug 01].

18.

Cell biology of the NCL proteins: What they do and don't do.

Cárcel-Trullols J, Kovács AD, Pearce DA.

Biochim Biophys Acta. 2015 May 8. pii: S0925-4439(15)00145-3. doi: 10.1016/j.bbadis.2015.04.027. [Epub ahead of print] Review.

PMID:
25962910
19.

Neuronal ceroid lipofuscinoses and possible pathogenic mechanism.

Zhong N.

Mol Genet Metab. 2000 Sep-Oct;71(1-2):195-206. Review.

PMID:
11001811
20.

Genetics of the neuronal ceroid lipofuscinoses (Batten disease).

Mole SE, Cotman SL.

Biochim Biophys Acta. 2015 May 27. pii: S0925-4439(15)00154-4. doi: 10.1016/j.bbadis.2015.05.011. [Epub ahead of print] Review.

PMID:
26026925
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk